name: Osteosarcoma
creation_date: '2026-02-02T00:16:36Z'
updated_date: '2026-02-17T21:53:14Z'
category: Cancer
parents:
- Bone Cancer
disease_term:
  preferred_term: osteosarcoma
  term:
    id: MONDO:0009807
    label: osteosarcoma
description: >-
  Osteosarcoma is the most common primary malignant bone tumor, most often
  affecting adolescents and young adults.
pathophysiology:
- name: Malignant Bone-Forming Tumor
  description: >-
    Malignant mesenchymal cells produce osteoid and invade bone, leading to an
    aggressive primary bone cancer.
  evidence:
  - reference: PMID:41154810
    supports: SUPPORT
    snippet: "Osteosarcoma (OS) is the most common primary malignant bone tumor, predominantly
      affecting adolescents and young adults."
    explanation: The abstract defines osteosarcoma as the most common primary
      malignant bone tumor.
- name: Tumor Immune Microenvironment Remodeling
  description: >-
    Osteosarcoma progression involves interactions with immune cells in the
    tumor microenvironment, including tumor-infiltrating lymphocytes and
    tumor-associated macrophages, alongside immune checkpoint expression.
  cell_types:
  - preferred_term: T cell
    term:
      id: CL:0000084
      label: T cell
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: immune response
    modifier: ABNORMAL
    term:
      id: GO:0006955
      label: immune response
  evidence:
  - reference: PMID:41154810
    supports: SUPPORT
    snippet: "We discuss classic morphologic and radiographic features alongside recent
      insights into the tumor microenvironment, including the role of tumor-infiltrating
      lymphocytes, tumor-associated macrophages, and immune checkpoint expression."
    explanation: The abstract highlights immune microenvironment components in
      osteosarcoma.
- name: PI3K/Akt Pathway Hyperactivation
  description: >-
    The PI3K/Akt signaling pathway is frequently hyperactivated in osteosarcoma
    and contributes to tumor initiation and progression.
  evidence:
  - reference: PMID:25704303
    supports: SUPPORT
    snippet: "An increasing body of evidence has shown that this pathway is frequently
      hyperactivated in OS and contributes to disease initiation and development,
      including tumorigenesis, proliferation, invasion, cell cycle progression, inhibition
      of apoptosis, angiogenesis, metastasis and chemoresistance."
    explanation: The abstract describes PI3K/Akt hyperactivation contributing to
      osteosarcoma progression.
treatments:
- name: Surgical Resection
  description: Surgical removal of the primary tumor when feasible.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:41154810
    supports: SUPPORT
    snippet: "Despite advances in surgery and multi-agent chemotherapy, survival rates
      for metastatic or recurrent OS remain poor, highlighting the need for novel
      prognostic and therapeutic strategies."
    explanation: The abstract references surgery as a standard component of
      osteosarcoma treatment.
- name: Multi-Agent Chemotherapy
  description: Combination chemotherapy used in neoadjuvant and adjuvant
    settings.
  treatment_term:
    preferred_term: chemotherapy
    term:
      id: MAXO:0000647
      label: chemotherapy
  evidence:
  - reference: PMID:41154810
    supports: SUPPORT
    snippet: "Despite advances in surgery and multi-agent chemotherapy, survival rates
      for metastatic or recurrent OS remain poor, highlighting the need for novel
      prognostic and therapeutic strategies."
    explanation: The abstract notes multi-agent chemotherapy as a standard
      therapy.
phenotypes:
- name: Bone Pain
  category: Musculoskeletal
  frequency: COMMON
  phenotype_term:
    preferred_term: Bone pain
    term:
      id: HP:0002653
      label: Bone pain
  evidence:
  - reference: PMID:35164914
    supports: SUPPORT
    snippet: "Osteosarcoma most frequently presents with localized bone pain, swelling,
      and an antalgic gait."
    explanation: The abstract lists localized bone pain as a typical presenting
      symptom.
- name: Gait Disturbance
  category: Neurologic
  frequency: COMMON
  phenotype_term:
    preferred_term: Gait disturbance
    term:
      id: HP:0001288
      label: Gait disturbance
  evidence:
  - reference: PMID:35164914
    supports: SUPPORT
    snippet: "Osteosarcoma most frequently presents with localized bone pain, swelling,
      and an antalgic gait."
    explanation: The abstract notes an antalgic gait as a common presentation.
datasets:
- accession: geo:GSE42352
  title: Genome-wide gene expression profiling of mesenchymal stem cells,
    osteosarcoma cells, and osteosarcoma cell lines.
  description: >-
    Microarray dataset of osteosarcoma and normal bone samples used for
    differential expression analyses.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MICROARRAY
  sample_types:
  - preferred_term: bone tissue
    tissue_term:
      preferred_term: bone element
      term:
        id: UBERON:0001474
        label: bone element
  sample_count: 118
  conditions:
  - osteosarcoma
  - normal bone tissue
  notes: >-
    Includes 103 osteosarcoma samples and 15 normal tissue samples.
references:
- reference: DOI:10.1002/pdi3.18
  title: Metabolic reprogramming in osteosarcoma
  findings: []
- reference: DOI:10.1007/s00432-024-05787-2
  title: Single-cell transcriptomic insights into chemotherapy-induced
    remodeling of the osteosarcoma tumor microenvironment
  findings: []
- reference: DOI:10.1038/s41413-022-00237-6
  title: Characterizing the tumor microenvironment at the single-cell level
    reveals a novel immune evasion mechanism in osteosarcoma
  findings: []
- reference: DOI:10.1073/pnas.0805462105
  title: Metastatic osteosarcoma induced by inactivation of <i>Rb</i> and
    <i>p53</i> in the osteoblast lineage
  findings: []
- reference: DOI:10.1200/jco.2025.43.16_suppl.10045
  title: '<i>MYC</i> amplification as a prognostic biomarker in osteosarcoma: A report
    from the Children’s Oncology Group.'
  findings: []
- reference: DOI:10.3389/fcell.2021.645381
  title: miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
  findings: []
- reference: DOI:10.3389/fcell.2021.737314
  title: 'Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions
    and Potential Clinical Applications'
  findings: []
- reference: DOI:10.3389/fcell.2023.1123065
  title: 'The interaction between osteosarcoma and other cells in the bone microenvironment:
    From mechanism to clinical applications'
  findings: []
- reference: DOI:10.3389/fimmu.2025.1579822
  title: 'Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular
    therapies'
  findings: []
- reference: DOI:10.3389/fimmu.2025.1584450
  title: 'Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic
    insights'
  findings: []
- reference: DOI:10.3389/fonc.2020.00406
  title: Downregulation of miR-22 Contributes to Epithelial-Mesenchymal
    Transition in Osteosarcoma by Targeting Twist1
  findings: []
- reference: DOI:10.3389/fonc.2020.563255
  title: LncRNA NR_027471 Functions as a ceRNA for miRNA-8055 Leading to
    Suppression of Osteosarcoma by Regulating the Expression of TP53INP1
  findings: []
- reference: DOI:10.3389/fonc.2023.1117867
  title: Molecular mechanisms of osteosarcoma metastasis and possible treatment
    opportunities
  findings: []
- reference: DOI:10.3389/fphar.2024.1350187
  title: Hypoxia inducible factor-1ɑ as a potential therapeutic target for
    osteosarcoma metastasis
  findings: []
- reference: DOI:10.3389/fphar.2024.1459057
  title: 'Cell cycle checkpoint revolution: targeted therapies in the fight against
    malignant tumors'
  findings: []
- reference: DOI:10.3389/fpubh.2021.813625
  title: The Construction and Development of a Clinical Prediction Model to
    Assess Lymph Node Metastases in Osteosarcoma
  findings: []
- reference: DOI:10.3390/biom14020145
  title: 'Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge
    and Limitations'
  findings: []
- reference: DOI:10.3390/ijms241310463
  title: Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes
    Related to Metastasis and Prognosis and Disrupted Biological Pathways of
    Immune Response and Bone Development
  findings: []
- reference: DOI:10.3390/ijms241411367
  title: Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
  findings: []
- reference: DOI:10.3892/ijmm.2025.5533
  title: 'Harnessing multi‑omics to revolutionize understanding and management of
    osteosarcoma: A pathway to precision medicine (Review)'
  findings: []
- reference: PMID:15736406
  title: Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in
    comparison to human osteoblasts.
  findings: []
- reference: PMID:278229
  title: Early lymphatic spread of osteogenic and soft-tissue sarcomas.
  findings: []
- reference: PMID:28370561
  title: Wnt/β-Catenin Signaling Activates Expression of the Bone-Related
    Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
  findings: []
- reference: PMID:289343
  title: 'Osteosarcoma: histological evaluation and grading.'
  findings: []
- reference: PMID:39615111
  title: The role of lncRNA and miRNA on the effects of occurrence and
    development of osteosarcoma.
  findings: []
- reference: PMID:8781571
  title: Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
  findings: []
